Early test for Longer-Lasting hemophilia treatment
NCT ID NCT05042440
Summary
This small, early study aimed to measure how long a new experimental drug (BIVV001) stays active in the body compared to two standard treatments for severe hemophilia A. It involved 13 adult men who had previously been treated for their condition. Researchers gave each participant a single dose of each drug in a set order and tracked how the body processed them to see if the new drug might last longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number :1000001
Sofia, 1756, Bulgaria
Conditions
Explore the condition pages connected to this study.